Patents by Inventor James Campbell ROBERTSON

James Campbell ROBERTSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted aminopyridine compounds as EGFR inhibitors
    Patent number: 11981658
    Abstract: Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.
    Type: Grant
    Filed: August 26, 2022
    Date of Patent: May 14, 2024
    Assignees: Yuhan Corporation, Janssen Biotech, Inc.
    Inventors: Byoungmoon Lee, Hyunjoo Lee, Gyu Jin Lee, Su Bin Choi, Sol Park, Heejun Kim, Misong Kim, Young Ae Yoon, Kwan Hoon Hyun, Tae Kyun Kim, Jae Young Sim, Marian C. Bryan, Scott Kuduk, James Campbell Robertson
  • Substituted aminopyridine compounds as EGFR inhibitors
    Patent number: 11945798
    Abstract: Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.
    Type: Grant
    Filed: August 26, 2022
    Date of Patent: April 2, 2024
    Assignees: YUHAN CORPORATION, JANSSEN BIOTECH, INC.
    Inventors: Hyunjoo Lee, Su Bin Choi, Young Ae Yoon, Kwan Hoon Hyun, Jae Young Sim, Marian C. Bryan, Scott Kuduk, James Campbell Robertson, Jaekyoo Lee, Paresh Devidas Salgaonkar, Byung-Chul Suh, Jong Sung Koh, So Young Hwang
  • 5-MEMBERED HETEROARYL-CONTAINING AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS
    Publication number: 20230085912
    Abstract: Provided are 5-membered heteroaryl-containing aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.
    Type: Application
    Filed: August 26, 2022
    Publication date: March 23, 2023
    Applicants: YUHAN CORPORATION, JANSSEN BIOTECH, INC.
    Inventors: Byoungmoon LEE, Hyunjoo LEE, Gyu Jin LEE, Su Bin CHOI, Misong KIM, Young Ae YOON, Kwan Hoon HYUN, Jae Young SIM, Marian C. BRYAN, Scott KUDUK, James Campbell ROBERTSON, Jaekyoo LEE, Paresh Devidas SALGAONKAR, Byung-Chul SUH, Jong Sung KOH, So Young HWANG
  • SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS
    Publication number: 20230086795
    Abstract: Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.
    Type: Application
    Filed: August 26, 2022
    Publication date: March 23, 2023
    Applicants: YUHAN CORPORATION, JANSSEN BIOTECH, INC.
    Inventors: Hyunjoo LEE, Su Bin CHOI, Young Ae YOON, Kwan Hoon HYUN, Jae Young SIM, Marian C. BRYAN, Scott KUDUK, James Campbell Robertson, Jaekyoo LEE, Paresh Devidas SALGAONKAR, Byung-Chul SUH, Jong Sung KOH, So Young HWANG
  • SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS
    Publication number: 20230086884
    Abstract: Provided are aminopyridine compounds and pharmaceutically acceptable compositions thereof which exhibit inhibition activity against certain mutated forms of EGFR.
    Type: Application
    Filed: August 26, 2022
    Publication date: March 23, 2023
    Applicants: YUHAN CORPORATION, JANSSEN BIOTECH, INC.
    Inventors: Byoungmoon LEE, Hyunjoo LEE, Gyu Jin LEE, Su Bin CHOI, Sol PARK, Heejun KIM, Misong KIM, Young Ae YOON, Kwan Hoon HYUN, Tae Kyun KIM, Jae Young SIM, Marian C. BRYAN, Scott KUDUK, James Campbell ROBERTSON